University of California, Irvine
Internal Medicine residency · Orange, CA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of California, Irvine's research in internal medicine, which the program shares with other departments and affiliated hospitals.
About University of California, Irvineinstitution-wide internal medicine research
Internal Medicine publications from University of California, Irvine and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
664
works per year
49th of 129 internal medicine residency programs
+8.4%
2-year growth
63rd of 129 internal medicine residency programs
23.8%
in top 10% of field (works before 2025)
59th of 120 internal medicine residency programs
44.9%
cited above world average
60th of 120 internal medicine residency programs
Works per year · * 2026 so far
Pulmonary and Respiratory Medicine · 673Oncology · 621Cardiology and Cardiovascular Medicine · 445Infectious Diseases · 439Endocrinology, Diabetes and Metabolism · 271
Internal Medicine research topics at University of California, Irvine
Papers in the window; each links to the list on OpenAlex.
- Lung Cancer Treatments and Mutations 179
- Tuberculosis Research and Epidemiology 97
- Heart Rate Variability and Autonomic Control 90
- Cancer survivorship and care 83
- Cancer Immunotherapy and Biomarkers 78
- SARS-CoV-2 and COVID-19 Research 72
- COVID-19 Clinical Research Studies 68
- Dialysis and Renal Disease Management 59
Most cited at University of California, Irvine since 2024
All internal medicine papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung CancerAlexander Edward Dela Cruz Drilon et al. · New England Journal of Medicine · 2024 · PubMed · cited 246
- Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent Lingzhi Chen et al. · Hepatology · 2024 · PubMed · cited 227
- Management of Locally Advanced Rectal Cancer: ASCO GuidelineAaron James Scott et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 204
- Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trialEgbert Frederik Smit et al. · The Lancet Oncology · 2024 · PubMed · cited 197
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- Recent advancements in cartilage tissue engineering innovation and translationRachel C. Nordberg et al. · Nature Reviews Rheumatology · 2024 · PubMed · cited 165
- Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of AmericaMichael Alan Horberg et al. · Clinical Infectious Diseases · 2024 · PubMed · cited 158
- Overall Survival with Amivantamab–Lazertinib in EGFR -Mutated Advanced NSCLCJames Chih‐Hsin Yang et al. · New England Journal of Medicine · 2025 · PubMed · cited 152
- Efficacy of Zenocutuzumab in NRG1 Fusion–Positive CancerAlison M. Schram et al. · New England Journal of Medicine · 2025 · PubMed · cited 148